LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 639

Search options

  1. Article ; Online: Alzheimer's Disease Biomarkers - Timing Is Everything.

    Mayeux, Richard

    The New England journal of medicine

    2024  Volume 390, Issue 8, Page(s) 761–763

    MeSH term(s) Humans ; Alzheimer Disease/diagnosis ; Amyloid beta-Peptides ; Biomarkers/analysis ; Disease Progression ; tau Proteins ; Time Factors
    Chemical Substances Amyloid beta-Peptides ; Biomarkers ; tau Proteins
    Language English
    Publishing date 2024-02-21
    Publishing country United States
    Document type Editorial
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMe2400102
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: A global view of the genetic basis of Alzheimer disease.

    Reitz, Christiane / Pericak-Vance, Margaret A / Foroud, Tatiana / Mayeux, Richard

    Nature reviews. Neurology

    2023  Volume 19, Issue 5, Page(s) 261–277

    Abstract: The risk of Alzheimer disease (AD) increases with age, family history and informative genetic variants. Sadly, there is still no cure or means of prevention. As in other complex diseases, uncovering genetic causes of AD could identify underlying ... ...

    Abstract The risk of Alzheimer disease (AD) increases with age, family history and informative genetic variants. Sadly, there is still no cure or means of prevention. As in other complex diseases, uncovering genetic causes of AD could identify underlying pathological mechanisms and lead to potential treatments. Rare, autosomal dominant forms of AD occur in middle age as a result of highly penetrant genetic mutations, but the most common form of AD occurs later in life. Large-scale, genome-wide analyses indicate that 70 or more genes or loci contribute to AD. One of the major factors limiting progress is that most genetic data have been obtained from non-Hispanic white individuals in Europe and North America, preventing the development of personalized approaches to AD in individuals of other ethnicities. Fortunately, emerging genetic data from other regions - including Africa, Asia, India and South America - are now providing information on the disease from a broader range of ethnicities. Here, we summarize the current knowledge on AD genetics in populations across the world. We predominantly focus on replicated genetic discoveries but also include studies in ethnic groups where replication might not be feasible. We attempt to identify gaps that need to be addressed to achieve a complete picture of the genetic and molecular factors that drive AD in individuals across the globe.
    MeSH term(s) Middle Aged ; Humans ; Alzheimer Disease/genetics ; Genome-Wide Association Study ; Genetic Predisposition to Disease/genetics ; Mutation ; Ethnicity
    Language English
    Publishing date 2023-04-06
    Publishing country England
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 2491514-2
    ISSN 1759-4766 ; 1759-4758
    ISSN (online) 1759-4766
    ISSN 1759-4758
    DOI 10.1038/s41582-023-00789-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Effects of Vascular Risk Factors on the Association of Blood-Based Biomarkers with Alzheimer's Disease.

    Hoost, S S / Brickman, A M / Manly, J J / Honig, L S / Gu, Y / Sanchez, D / Reyes-Dumeyer, D / Lantigua, R A / Kang, M S / Dage, J L / Mayeux, R

    Medical research archives

    2023  Volume 11, Issue 9

    Abstract: Background: Comorbidities may influence the levels of blood-based biomarkers for Alzheimer's disease (AD). We investigated whether differences in risk factors or comorbid conditions might explain the discordance between clinical diagnosis and biomarker ... ...

    Abstract Background: Comorbidities may influence the levels of blood-based biomarkers for Alzheimer's disease (AD). We investigated whether differences in risk factors or comorbid conditions might explain the discordance between clinical diagnosis and biomarker classifications in a multi-ethnic cohort of elderly individuals.
    Aims: To evaluate the relationship of medical conditions and other characteristics, including body mass index (BMI), vascular risk factors, and head injury, with cognitive impairment and blood-based biomarkers of AD, phosphorylated tau (P-tau 181, P-tau 217), in a multi-ethnic cohort.
    Methods: Three-hundred individuals, aged 65 and older, were selected from a prospective community-based cohort for equal representation among three racial/ethnic groups: non-Hispanic White, Hispanic/Latino and African American/Black. Participants were classified into four groups based on absence (Asym) or presence (Sym) of cognitive impairment and low (NEG) or high (POS) P-tau 217 or P-tau 181 levels, determined previously in the same cohort: (Asym/NEG, Asym/POS, Sym/NEG, Sym/POS). We examined differences in individual characteristics across the four groups. We performed post-hoc analysis examining the differences across biomarker and cognitive status.
    Results: P-tau 217 or P-tau 181 positive individuals had lower BMI than P-tau negative participants, regardless of symptom status. Symptomatic and asymptomatic participants did not differ in terms of BMI. BMI was not a mediator of the effect of P-tau 217 or P-tau 181 on dementia. Frequencies of other risk factors did not differ between the four groups of individuals.
    Conclusions: Participants with higher levels of P-tau 217 or P-tau 181 consistent with AD had lower BMI regardless of whether the individual was symptomatic. These findings suggest that weight loss may change with AD biomarker levels before onset of cognitive decline. They do not support BMI as a confounding variable. Further longitudinal studies could explore the relationship of risk factors with clinical diagnoses and biomarkers.
    Language English
    Publishing date 2023-10-04
    Publishing country United States
    Document type Journal Article
    ISSN 2375-1916
    ISSN 2375-1916
    DOI 10.18103/mra.v11i9.4468
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Clinical practice. Early Alzheimer's disease.

    Mayeux, Richard

    The New England journal of medicine

    2010  Volume 362, Issue 23, Page(s) 2194–2201

    MeSH term(s) Age of Onset ; Aged ; Alzheimer Disease/diagnosis ; Alzheimer Disease/drug therapy ; Alzheimer Disease/genetics ; Alzheimer Disease/psychology ; Cholinesterase Inhibitors/therapeutic use ; Diagnosis, Differential ; Disease Progression ; Humans ; Male ; Memantine/therapeutic use ; Memory Disorders/diagnosis ; Neuropsychological Tests ; Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors
    Chemical Substances Cholinesterase Inhibitors ; Receptors, N-Methyl-D-Aspartate ; Memantine (W8O17SJF3T)
    Language English
    Publishing date 2010-06-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJMcp0910236
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Reliability and Validity of self-reported Vascular Risk Factors in a Multi-Ethnic Community Based Study of Aging and Dementia.

    Lee, Annie J / Sanchez, Didi / Reyes-Dumeyer, Dolly / Brickman, Adam M / Lantigua, Rafael A / Vardarajan, Badri N / Mayeux, Richard

    medRxiv : the preprint server for health sciences

    2023  

    Abstract: Introduction: The reliability and validity of self-reported cardiovascular and cerebrovascular risk factors remains inconsistent in aging research.: Methods: We assessed the reliability, validity, sensitivity, specificity, and percent agreement of ... ...

    Abstract Introduction: The reliability and validity of self-reported cardiovascular and cerebrovascular risk factors remains inconsistent in aging research.
    Methods: We assessed the reliability, validity, sensitivity, specificity, and percent agreement of self-reported hypertension, diabetes, and heart disease, in comparison with direct measures of blood pressure, hemoglobin A1c (HbA1c), and medication use in 1870 participants in a multiethic study of aging and dementia.
    Results: Reliability of self-reported for hypertension, diabetes, and heart disease was excellent. Agreement between self-reports and clinical measures was moderate for hypertension (kappa: 0.58), good for diabetes (kappa: 0.76-0.79), and moderate for heart disease (kappa: 0.45) differing slightly by age, sex, education, and race/ethnic group. Sensitivity and specificity for hypertension was 88.6%-78.1%, for diabetes was 87.7%-92.0% (HbA1c > 6.5%) or 92.7%-92.8% (HbA1c > 7%), and for heart disease was 85.8%-75.5%.
    Discussion: Self-reported history of hypertension, diabetes, and heart disease are reliable and valid compared to direct measurements or medication use.
    Language English
    Publishing date 2023-04-17
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2023.04.12.23288492
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Lewis P. Rowland, MD: 1925-2017.

    Pedley, Timothy A / Mayeux, Richard

    Annals of neurology

    2017  Volume 81, Issue 5, Page(s) 620–621

    Language English
    Publishing date 2017-05-04
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80362-5
    ISSN 1531-8249 ; 0364-5134
    ISSN (online) 1531-8249
    ISSN 0364-5134
    DOI 10.1002/ana.24934
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses.

    Yang, Zikun / Wang, Chen / Liu, Linxi / Khan, Atlas / Lee, Annie / Vardarajan, Badri / Mayeux, Richard / Kiryluk, Krzysztof / Ionita-Laza, Iuliana

    Nature genetics

    2023  Volume 55, Issue 6, Page(s) 1057–1065

    Abstract: Fine-mapping is commonly used to identify putative causal variants at genome-wide significant loci. Here we propose a Bayesian model for fine-mapping that has several advantages over existing methods, including flexible specification of the prior ... ...

    Abstract Fine-mapping is commonly used to identify putative causal variants at genome-wide significant loci. Here we propose a Bayesian model for fine-mapping that has several advantages over existing methods, including flexible specification of the prior distribution of effect sizes, joint modeling of summary statistics and functional annotations and accounting for discrepancies between summary statistics and external linkage disequilibrium in meta-analyses. Using simulations, we compare performance with commonly used fine-mapping methods and show that the proposed model has higher power and lower false discovery rate (FDR) when including functional annotations, and higher power, lower FDR and higher coverage for credible sets in meta-analyses. We further illustrate our approach by applying it to a meta-analysis of Alzheimer's disease genome-wide association studies where we prioritize putatively causal variants and genes.
    MeSH term(s) Genome-Wide Association Study/methods ; Bayes Theorem ; Linkage Disequilibrium ; Polymorphism, Single Nucleotide
    Language English
    Publishing date 2023-05-11
    Publishing country United States
    Document type Meta-Analysis ; Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1108734-1
    ISSN 1546-1718 ; 1061-4036
    ISSN (online) 1546-1718
    ISSN 1061-4036
    DOI 10.1038/s41588-023-01392-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Reliability and Validity of Self-Reported Vascular Risk Factors: Hypertension, Diabetes, and Heart Disease, in a Multi-Ethnic Community Based Study of Aging and Dementia.

    Lee, Annie J / Sanchez, Didi / Reyes-Dumeyer, Dolly / Brickman, Adam M / Lantigua, Rafael A / Vardarajan, Badri N / Mayeux, Richard

    Journal of Alzheimer's disease : JAD

    2023  Volume 95, Issue 1, Page(s) 275–285

    Abstract: Background: Queries for the presence of cardiovascular and cerebrovascular risk factors are typically assessed through self-report. However, the reliability and validity of self-reported cardiovascular and cerebrovascular risk factors remain ... ...

    Abstract Background: Queries for the presence of cardiovascular and cerebrovascular risk factors are typically assessed through self-report. However, the reliability and validity of self-reported cardiovascular and cerebrovascular risk factors remain inconsistent in aging research.
    Objective: To determine the reliability and validity of the most frequently self-reported vascular risk factors: hypertension, diabetes, and heart disease.
    Methods: 1,870 individuals aged 65 years or older among African Americans, Caribbean Hispanics, and white non-Hispanic individuals were recruited as part of a community study of aging and dementia. We assessed the reliability, validity, sensitivity, specificity, and percent agreement of self-reported hypertension, diabetes, and heart disease, in comparison with direct measures of blood pressure, hemoglobin A1c (HbA1c), and medication use. The analyses were subsequently stratified by age, sex, education, and ethnic group.
    Results: Reliability of self-reported hypertension, diabetes, and heart disease was excellent. Agreement between self-reports and clinical measures was moderate for hypertension (kappa: 0.58), good for diabetes (kappa: 0.76-0.79), and moderate for heart disease (kappa: 0.45) differing slightly by age, sex, education, and ethnic group. Sensitivity and specificity for hypertension was 88.6% -78.1%, for diabetes was 87.7% -92.0% (HbA1c ≥6.5%) or 92.7% -92.8% (HbA1c ≥7%), and for heart disease was 85.8% -75.5%. Percent agreement of self-reported was 87.0% for hypertension, 91.6% -92.6% for diabetes, and 77.4% for heart disease.
    Conclusion: Ascertainment of self-reported histories of hypertension, diabetes, and heart disease are reliable and valid compared to direct measurements or medication use.
    MeSH term(s) Humans ; Self Report ; Glycated Hemoglobin ; Reproducibility of Results ; Diabetes Mellitus/epidemiology ; Hypertension/epidemiology ; Aging ; Heart Diseases/diagnosis ; Heart Diseases/epidemiology ; Risk Factors ; Dementia/diagnosis ; Dementia/epidemiology
    Chemical Substances Glycated Hemoglobin
    Language English
    Publishing date 2023-07-24
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230374
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Can estrogen or selective estrogen-receptor modulators preserve cognitive function in elderly women?

    Mayeux, R

    The New England journal of medicine

    2001  Volume 344, Issue 16, Page(s) 1242–1244

    MeSH term(s) Animals ; Cognition/drug effects ; Estrogen Replacement Therapy ; Estrogens/pharmacology ; Estrogens/therapeutic use ; Female ; Humans ; Postmenopause/drug effects ; Postmenopause/psychology ; Raloxifene Hydrochloride/pharmacology ; Raloxifene Hydrochloride/therapeutic use ; Selective Estrogen Receptor Modulators/pharmacology ; Selective Estrogen Receptor Modulators/therapeutic use
    Chemical Substances Estrogens ; Selective Estrogen Receptor Modulators ; Raloxifene Hydrochloride (4F86W47BR6)
    Language English
    Publishing date 2001-04-19
    Publishing country United States
    Document type Comment ; Editorial
    ZDB-ID 207154-x
    ISSN 1533-4406 ; 0028-4793
    ISSN (online) 1533-4406
    ISSN 0028-4793
    DOI 10.1056/NEJM200104193441610
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Genomic variation in educational attainment modifies Alzheimer disease risk.

    Raghavan, Neha S / Vardarajan, Badri / Mayeux, Richard

    Neurology. Genetics

    2019  Volume 5, Issue 2, Page(s) e310

    Abstract: Objective: To determine the putative protective relationship of educational attainment on Alzheimer disease (AD) risk using Mendelian randomization and to test the hypothesis that by using genetic regions surrounding individually associated single ... ...

    Abstract Objective: To determine the putative protective relationship of educational attainment on Alzheimer disease (AD) risk using Mendelian randomization and to test the hypothesis that by using genetic regions surrounding individually associated single nucleotide polymorphisms (SNPs) as the instrumental variable, we can identify genes that contribute to the relationship.
    Methods: We performed Mendelian randomization using genome-wide association study summary statistics from studies of educational attainment and AD in two stages. Our instrumental variable comprised (1) 1,271 SNPs significantly associated with educational attainment and (2) individual 2-Mb regions surrounding the genome-wide significant SNPs.
    Results: A causal inverse relationship between educational attainment and AD was identified by the 1,271 SNPs (odds ratio = 0.63; 95% confidence interval, 0.54-0.74;
    Conclusions: Educational attainment is an important protective factor for AD. Genomic regions that significantly paralleled the overall causal relationship contain genes expressed in neurons or involved in the regulation of neuronal development.
    Language English
    Publishing date 2019-02-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2818607-2
    ISSN 2376-7839
    ISSN 2376-7839
    DOI 10.1212/NXG.0000000000000310
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top